Glaucoma · Eye drops

Private Simbrinza (brinzolamide/brimonidine) glaucoma drops

A twice-daily fixed-combination eye drop that lowers eye pressure two ways at once — the carbonic anhydrase inhibitor brinzolamide paired with the alpha-2 agonist brimonidine — for open-angle glaucoma and ocular hypertension. Because it contains no prostaglandin or beta-blocker, it suits patients who cannot use, or want to avoid, those drug classes.

Twice dailyOne drop, morning & evening
Two mechanismsCAI + alpha-2 agonist
Prostaglandin-freeNo beta-blocker either
Book a consultation Call 0800 852 7782

Simbrinza is a twice-daily fixed-combination eye drop that combines brinzolamide 10 mg/ml (a carbonic anhydrase inhibitor) with brimonidine 2 mg/ml (an alpha-2 adrenergic agonist) to lower intraocular pressure in open-angle glaucoma and ocular hypertension. It is used when a single drop has not lowered pressure enough, and is a useful prostaglandin-free, beta-blocker-free option for patients who cannot tolerate those classes. Our consultant glaucoma specialists confirm suitability, prescribe it and monitor your pressure and optic nerve.

What Simbrinza is

Simbrinza pairs two pressure-lowering medicines with complementary actions in a single bottle. Brinzolamide, a carbonic anhydrase inhibitor, reduces the production of aqueous fluid inside the eye. Brimonidine, an alpha-2 agonist, both reduces fluid production and increases its drainage through the uveoscleral route. Because the two act in different ways, the combination lowers eye pressure more than either drop alone — without using a prostaglandin or a beta-blocker.

It is prescribed for adults with open-angle glaucoma or ocular hypertension whose pressure stays too high on a single medicine, and is particularly helpful for people who cannot use a beta-blocker (for example because of asthma or certain heart conditions) or who have not tolerated a prostaglandin. For a prostaglandin-based fixed combination, compare Roclanda.

How to use it

The dose is one drop in the affected eye(s) twice daily, morning and evening. Shake the bottle before use. If you use other eye drops, leave at least five minutes between them, and remove contact lenses before instilling the drop (they can be replaced after 15 minutes). Gently pressing the inner corner of the eye for a minute after the drop reduces the amount absorbed into the body. Taking it at the same times each day gives the steadiest pressure control.

Pressure not controlled on a single drop, or unable to use a prostaglandin or beta-blocker? A consultant can review whether Simbrinza suits you.

Book your assessment

Suitability & side effects

Simbrinza suits people who need more pressure reduction than one drop provides and who want to avoid — or cannot take — a prostaglandin or beta-blocker. The most common effects are blurred vision just after instilling, eye irritation or redness, an unusual or bitter taste, and dry mouth. Because it is a carbonic anhydrase inhibitor, brinzolamide is a sulfonamide and should be avoided if you are allergic to sulfonamide medicines; it is also not suitable in severe kidney impairment. Brimonidine can occasionally cause drowsiness and is not used in young children, and care is needed with certain antidepressants (MAOIs). Your consultant weighs these against the benefit of avoiding surgery and reviews alternatives — including SLT laser and glaucoma surgery — if drops are not tolerated or not enough.

Cost of private Simbrinza treatment

The drop itself is a standard prescription medicine dispensed at pharmacy cost; the main private cost is the specialist care around it. A consultant glaucoma assessment from £240 covers your pressure check, optic-nerve and visual-field assessment, the prescription and a monitoring plan. Because glaucoma needs lifelong follow-up, most patients arrange periodic reviews. See the full glaucoma price guide, the glaucoma treatment prices, or the overall price guide.

Frequently asked questions

What is Simbrinza used for?

Simbrinza is a twice-daily eye drop for adults with open-angle glaucoma or ocular hypertension. It combines brinzolamide (a carbonic anhydrase inhibitor) and brimonidine (an alpha-2 agonist) to lower intraocular pressure, used when a single-agent drop has not reduced pressure enough, especially when a prostaglandin or beta-blocker is unsuitable.

How does Simbrinza lower eye pressure?

It works in two complementary ways. Brinzolamide reduces the production of fluid inside the eye, while brimonidine both reduces fluid production and increases its drainage, so together they lower pressure more than either drug alone.

How often do I use Simbrinza?

One drop in the affected eye(s) twice daily, morning and evening. Shake the bottle first, leave at least five minutes between Simbrinza and any other eye drops, and remove contact lenses before use, replacing them after 15 minutes.

What are the side effects of Simbrinza?

Common effects include brief blurred vision after instilling, eye irritation or redness, an unusual or bitter taste and dry mouth. It contains a sulfonamide (brinzolamide), so it is avoided in sulfonamide allergy and severe kidney impairment; brimonidine can occasionally cause drowsiness. Your consultant will discuss these and monitor you.

What if drops do not control my glaucoma?

If pressure stays high or drops are not tolerated, options include SLT laser trabeculoplasty and glaucoma surgery such as MIGS or trabeculectomy. A consultant assessment determines the best next step for your eyes.

Book a private glaucoma consultation

Get a consultant assessment of your eye pressure and optic nerve, and a clear plan — whether that is Simbrinza, another drop, laser or surgery.

Updated on 22 Jun 2026